ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q3SCImago #10,900Hybrid

Journal De Mycologie Medicale

Abbreviation (ISO):J MYCOL MED
•
Identifier (ISSN):1156-5233(Print)/1773-0449(Online)
•
Publisher:Elsevier Masson
Clarivate IF (2026)
2.4↑ +0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal De Mycologie Medicale

WoS Q3
12451.6120181.4820191.5620202.3920213.7520223.620232.220241.820252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q3
0.545
#10,900

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
50

50 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
69articles/year
17.24% Gold OA•74.12% Original Research

Aims & Scope

The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity. JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered. Under no circumstances does the journal guarantee publication before the editorial board makes its final decision. The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.

Topics Covered (Recognized by AI)
Biology79.7%Medicine78.6%Microbiology57%Dermatology45%Botany43.1%Genetics42.8%Chemistry36.2%Antifungal34.1%Biochemistry29.5%Immunology28.9%Pathology21.9%Internal medicine21.2%Gynecology21%Surgery20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MYCOLOGY

Q3
Rank22/33
IndexSCIE
JCISCIE2026

MYCOLOGY

Q3
Rank23/33
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.4
Articles / Year37
Total Citations5
2025
IF1.8
Articles / Year59
Total Citations79
2024
IF2.2
Articles / Year58
Total Citations172
2023
IF3.6
Articles / Year65
Total Citations423
2022
IF3.746
Articles / Year77
Total Citations698

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,900Scopus Q3SCImago Profile
Scopus Coverage:1994-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.545

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
2.50

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,919 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations477
3-Year Documents204
Citable Documents187

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区MYCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal De Mycologie Medicale (abbr: J MYCOL MED, ISSN: 1156-5233) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Masson in France since 1991. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.545 (Q3), an H-index of 50.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 69 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,919 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Masson
Publication Language
Multi-Language
Frequency
Quarterly
Founding Year
1991
Indexing & Databases
SCIEScopusPubMed
Editorial Address
MASSON EDITEUR, 21 STREET CAMILLE DESMOULINS, ISSY, MOULINEAUX CEDEX 9, FRANCE, 92789

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 0ef73d1e-c92d-469b-bea8-a8c68e79aa55
Database Updated: 2026-10-16